As of April 18, 2025, Biodesix (BDSX) has a market cap of $80.142 million USD. According to our data, Biodesix is ranked No.7743 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $80.14 M |
-63.99%
|
Dec 31, 2024 | $0.22 B |
-16.85%
|
Dec 29, 2023 | $0.27 B |
-20.00%
|
Dec 30, 2022 | $0.33 B |
-56.52%
|
Dec 31, 2021 | $0.77 B |
-73.76%
|
Dec 31, 2020 | $2.93 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Veracyte
VCYT
|
$2.43 B |
0.000 M
|
![]() USA
|
![]() Guardant Health
GH
|
$5.55 B |
-0.000 M
|
![]() USA
|
![]() Exact Sciences
EXAS
|
$7.72 B |
-0.000 M
|
![]() USA
|
![]() Natera
NTRA
|
$20.02 B |
0.001 M
|
![]() USA
|
![]() Adaptive Biotechnologies
ADPT
|
$1.09 B |
0.000 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.23 B |
0.000 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() Personalis
PSNL
|
$0.28 B |
0.000 M
|
![]() USA
|
![]() OncoCyte
OCX
|
$81.22 M |
-0.000 M
|
![]() USA
|
![]() CareDx
CDNA
|
$0.98 B |
0.000 M
|
![]() USA
|
![]() T2 Biosystems
TTOO
|
$2.97 M |
0.000 M
|
![]() USA
|
Market Cap | = | BDSX Stock Price | * | BDSX Shares Outstanding |
= | $0.55 | * | 0.15 B | |
= | $80.14 M |